• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during breastfeeding and pregnancy is challenging for women with the condition. There aren't enough data on how long-term exposure may affect a pregnant fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological disorders like hearing or vision impairment seizures, febrile seizures or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to evaluate the benefits of using it against the potential risks for the fetus. Doctors don't have enough data to make unambiguous recommendations but they can provide information on the risks and benefits to assist pregnant women to make informed decisions.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy did not have a higher risk of fetal malformations, or structural birth defects. The researchers used a large, population-based case-control study to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants during the early stages of pregnancy, as well as those who had not. Clinical geneticists and pediatric cardiologists looked over the cases to ensure correct case classification and to minimize the possibility of bias.

However, the researchers' study was not without its flaws. The most important issue was that they were unable to distinguish the effects of the medication from the disorder that is underlying. This makes it difficult to determine whether the limited associations observed in the exposed groups are due to medication use or confounding by comorbidities. Additionally the researchers did not look at long-term offspring outcomes.

The study did show that infants whose mothers took ADHD medication during pregnancy were at a greater risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or stopped their medications before or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not affected by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have a caesarean section or one whose baby scored low on the Apgar scale (less than 7). These increases did not seem to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the small risks posed by the use of ADHD medications during early pregnancies can be offset by greater benefits to both mother and baby from continuing treatment for the woman's disorder. Physicians should discuss this with their patients and, where possible, assist them in developing strategies for improving their coping skills that may minimize the negative impact of her condition on her daily functioning and relationships.

Medication Interactions

Doctors are increasingly confronted with the dilemma of whether to keep treatment or stop as more women are diagnosed with ADHD. Often, these decisions are made in the absence of any evidence that is clear and definitive either way, so physicians have to weigh their experience about their experiences, the experiences of other doctors, and what the research suggests about the subject, along with their own best medication for ocd and adhd judgment for each individual patient.

The issue of possible risks for infants can be particularly tricky. Many of the studies on this issue are based on observational data rather than controlled research and their conclusions are often contradictory. Additionally, the majority of studies limit their analysis to live births, which can undervalue the serious teratogenic effects that can cause abortion or termination of the pregnancy. The study presented in this journal club addresses these issues by analyzing data on live and deceased births.

Conclusion Some studies have revealed an association between ADHD medications and certain birth defects, other studies have not found a correlation. The majority of studies show a neutral, or even slightly negative, impact. Therefore, a careful risk/benefit analysis must be conducted in every instance.

It isn't easy, but not impossible for women with intuniv adhd medication to stop taking their medication. In an article recently published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can lead to increased depression, feelings of loneliness, and family conflict for those suffering from the disorder. A loss of medication may affect the ability to safely drive and perform work-related tasks, which are vital aspects of daily life for those with best adhd medication for adults with anxiety and depression.

She suggests that women who aren't sure whether to take the medication or stop it due to their pregnancy should educate family members, coworkers and their friends about the condition, its effects on daily functioning, and the advantages of staying on the current treatment. It can also help a woman feel more confident in her decision. Certain medications can be passed through the placenta. If a patient decides not to take her ADHD medication while breastfeeding, it is important to be aware that the drug could be passed on to her baby.

Birth Defects and Risk of

As the use and use of ADHD drugs to treat symptoms of attention deficit disorder hyperactivity disorder (ADHD) increases the concern over the potential effects of these drugs on fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of information on this topic. Utilizing two huge data sets, researchers were able to examine more than 4.3 million pregnancies to determine whether stimulant medication use increased the risk of birth defects. While the overall risk is low, the researchers found that exposure in the first trimester to ADHD medications was linked to a slightly higher rate of specific heart defects, such as ventriculo-septal defect (VSD).

The researchers of the study didn't find any association between early medication usage and other congenital anomalies like facial deformities, or club feet. The results are in line with previous studies which showed a small, but significant increase in the number of cardiac malformations among women who began taking adhd inattentive Type medication medication before the time of pregnancy. The risk grew in the later part of pregnancy, when many women begin to discontinue their medication.

Women who took ADHD medication in the first trimester were more likely require a caesarean birth, have a low Apgar after delivery, and have a baby who needed help breathing at birth. However the authors of the study were not able to eliminate selection bias by limiting the study to women who did not have any other medical conditions that could have contributed to the findings.

The researchers hope their study will help inform the clinical decisions of doctors who encounter pregnant women. The researchers advise that, while discussing risks and benefits are important, the decision about whether to continue or stop medication should be made in light of the severity of each woman's ADHD symptoms and her needs.

The authors also caution that, while stopping the medication is an option, it is not an option to consider due to the high incidence of depression and other mental health problems among women who are pregnant or who are recently postpartum. Further, the research suggests that women who choose to stop taking their medication are more likely to experience difficulties adjusting to life without them after the birth of their baby.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women with ADHD who must work through their symptoms while attending physician appointments as well as preparing for the arrival of a baby and adapting to new routines in the home are often faced with a number of difficulties. Many women choose to continue taking their ADHD medication during pregnancy.

The majority of stimulant drugs are absorbed through breast milk in low quantities, so the risk to infant who is breastfeeding is low. However, the rate of exposure to medication by the infant can differ based on the dosage, frequency it is administered and at what time the medication is administered. In addition, various medications are introduced into the baby's system through the gastrointestinal tract or through breast milk. The impact on a newborn's health is not completely comprehended.

Some doctors may stop taking stimulant medication during a woman's pregnancy due to the lack of research. This is a complicated decision for the patient, who must balance the benefits of keeping her medication against the possible dangers to the foetus. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and whether they plan or are taking to take medication during the perinatal period.

Numerous studies have proven that women can continue taking their ADHD medication in a safe manner while breastfeeding and during pregnancy. As a result, many patients are choosing to do so, and after consulting with their doctor, they have found that the benefits of maintaining their current medication outweigh any potential risks.

It is essential for women with ADHD who are contemplating breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their prescriber and discuss the pros and cons for continuing treatment. This includes non prescription adhd medication-pharmacological strategies. Psychoeducation should also be provided to help pregnant people with ADHD recognize their symptoms and the root cause and learn about treatment options and reinforce existing strategies for coping. This should include an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Counselling for pregnancy should include the discussion of a treatment plan for both mother and child, as well as monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.